Generic Portal

Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma

Moehler, M., Högner, A., Wagner, A. D., Obermannova, R., Alsina, M., Thuss-Patience, P., van Laarhoven, H. & Smyth, E., 1 Nov 2022, In: European Journal of Cancer. 176, p. 13-29 17 p.

Research output: Contribution to journal › Article › Academic › peer-review

Recurrent Disease After Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study

Kalff, M. C., Henckens, S. P. G., Voeten, D. M., Heineman, D. J., Hulshof, M. C. C. M., van Laarhoven, H. W. M., Eshuis, W. J., Baas, P. C., Bahadoer, R. R., Belt, E. J. T., Brattinga, B., Claassen, L., Ćosović, A., Crull, D., Daams, F., van Dalsen, A. D., Dekker, J. W. T., van Det, M. J., Drost, M., van Duijvendijk, P., & 41 othersvan Esser, S., Gaspersz, M. P., Görgec, B., Groenendijk, R. P. R., Hartgrink, H. H., van der Harst, E., Haveman, J. W., Heisterkamp, J., van Hillegersberg, R., Kelder, W., Kingma, B. F., Koemans, W. J., Kouwenhoven, E. A., Lagarde, S. M., Lecot, F., van der Linden, P. P., Luyer, M. D. P., Nieuwenhuijzen, G. A. P., Olthof, P. B., van der Peet, D. L., Pierie, J-P. E. N., Pierik, E. G. J. M. R., Plat, V. D., Polat, F., Rosman, C., Ruurda, J. P., van Sandick, J. W., Scheer, R., Slootmans, C. A. M., Sosef, M. N., Sosef, O. V., de Steur, W. O., Stockmann, H. B. A. C., Stoop, F. J., Vugts, G., Vijgen, G. H. E. J., Weeda, V. O. B., Wiezer, M. J., van Oijen, M. G. H., van Berge Henegouwen, M. I. & Gisbertz, S. S., 1 Nov 2022, In: Annals of surgery. 276, 5, p. 806-813 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study

Kroese, T. E., Jorritsma, N. K. N., van Laarhoven, H. W. M., Verhoeven, R. H. A., Mook, S., Haj Mohammad, N., Ruurda, J. P., van Rossum, P. S. N. & van Hillegersberg, R., 1 Nov 2022, In: Clinical and Translational Radiation Oncology. 37, p. 109-115 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

Öcal, O., Schütte, K., Zech, C. J., Loewe, C., van Delden, O., Vandecaveye, V., Verslype, C., Gebauer, B., Sengel, C., Bargellini, I., Iezzi, R., Philipp, A., Berg, T., Klümpen, H. J., Benckert, J., Pech, M., Gasbarrini, A., Amthauer, H., Bartenstein, P., Sangro, B., & 3 othersMalfertheiner, P., Ricke, J. & Seidensticker, M., Nov 2022, In: European journal of nuclear medicine and molecular imaging. 49, 13, p. 4716-4726 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres

Zandee, W. T., Merola, E., Poczkaj, K., de Mestier, L., Klümpen, H-J., Geboes, K., de Herder, W. W. & Munir, A., Nov 2022, In: European journal of cancer care. 31, 6, e13639.

Research output: Contribution to journal › Article › Academic › peer-review

Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer

de Ruiter, B-M., van Hattum, J. W., Lipman, D., de Reijke, T. M., van Moorselaar, R. J. A., van Gennep, E. J., Maartje Piet, A. H., Donker, M., van der Hulle, T., Voortman, J., Oddens, J. R., Hulshof, M. C. C. M. & Bins, A. D., Nov 2022, In: European urology. 82, 5, p. 518-526 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy

van den Bosch, T., Rueda, O. M., Caldas, C., Vermeulen, L. & Miedema, D. M., 19 Oct 2022, In: British journal of cancer. 127, 7, p. 1332-1339 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Team dynamics and clinician’s experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study

Luijten, J. C. H. B. M., Westerman, M. J., Nieuwenhuijzen, G. A. P., Walraven, J. E. W., Sosef, M. N., Beerepoot, L. V., van Hillegersberg, R., Muller, K., Hoekstra, R., Bergman, J. J. G. H. M., Siersema, P. D., van Laarhoven, H. W. M., Rosman, C., Brom, L., Vissers, P. A. J. & Verhoeven, R. H. A., 18 Oct 2022, In: Frontiers in oncology. 12, 1003506.

Research output: Contribution to journal › Article › Academic › peer-review

Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX

van Dijk, E., van Werkhoven, E., Asher, R., Mooi, J. K., Espinoza, D., van Essen, H. F., van Tinteren, H., van Grieken, N. C. T., Punt, C. J. A., Tebbutt, N. C. & Ylstra, B., 1 Oct 2022, In: International Journal of Cancer. 151, 7, p. 1166-1174 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Reply to W. Attaallah, A. Jain et al, and P. Mroczkowski et al

Versteijne, E., van Dam, J. L., Besselink, M. G., Groot Koerkamp, B., Homs, M. Y. V., Wilmink, J. W., van Eijck, C. H. & van Tienhoven, G., 1 Oct 2022, In: Journal of clinical oncology. 40, 28, p. 3348-3350 3 p.

Research output: Contribution to journal › Article › Academic › peer-review